The global market for EGFR Inhibitors for Lung Cancer is estimated to increase from US$ million in 2024 to reach US$ million by 2031, exhibiting a CAGR of % during 2025-2031. Keeping in mind the uncertainties of Trade War and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of trade war on different end use sectors. These insights are included in the report as a major market contributor.
The APAC EGFR Inhibitors for Lung Cancer market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The United States EGFR Inhibitors for Lung Cancer market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The Europe EGFR Inhibitors for Lung Cancer market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The China EGFR Inhibitors for Lung Cancer market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
Global key EGFR Inhibitors for Lung Cancer players cover Pfizer, AstraZeneca, Genentech (Roche Group), Beta Pharma and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2024.

[Report Coverage]
This latest report provides a deep insight into the global EGFR Inhibitors for Lung Cancer market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global EGFR Inhibitors for Lung Cancer market, with both quantitative and qualitative data, to help readers understand how the EGFR Inhibitors for Lung Cancer market scenario changed across the globe during trade war and Russia-Ukraine War.
The base year considered for analyses is 2024, while the market estimates and forecasts are given from 2025 to 2031. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

[Market Segmentation]
The study segments the EGFR Inhibitors for Lung Cancer market and forecasts the market size by Type (Geftinib, Afatinib and Osimertinib), by Application (Medical Care, Experiment and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Geftinib
Afatinib
Osimertinib
Other
Segmentation by application
Medical Care
Experiment
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Pfizer
AstraZeneca
Genentech (Roche Group)
Beta Pharma
Mylan
Boehringer Ingelheim
Teva Pharmaceuticals
Qilu Pharmaceutical
Betta Pharmaceuticals
Haosen Pharmaceutical
ARIAD Pharmaceuticals
HUTCHMED
Shanghai Ellis
Genvio Pharma
Everest Pharmaceuticals
Incepta Pharmaceuticals
Jiangsu Hengrui Medicine

[Chapter Introduction]
Chapter 1: Scope of EGFR Inhibitors for Lung Cancer, Research Methodology, etc.
Chapter 2: Executive Summary, global EGFR Inhibitors for Lung Cancer market size (sales and revenue) and CAGR, EGFR Inhibitors for Lung Cancer market size by region, by type, by application, historical data from 2020 to 2025, and forecast to 2031.
Chapter 3: EGFR Inhibitors for Lung Cancer sales, revenue, average price, global market share, and industry ranking by company, 2020-2024
Chapter 4: Global EGFR Inhibitors for Lung Cancer sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global EGFR Inhibitors for Lung Cancer market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer, AstraZeneca, Genentech (Roche Group), Beta Pharma, Mylan, Boehringer Ingelheim, Teva Pharmaceuticals, Qilu Pharmaceutical and Betta Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion

List of Tables
Table 1. EGFR Inhibitors for Lung Cancer Annual Sales CAGR by Geographic Region (2020, 2025 & 2031) & ($ millions)
Table 2. EGFR Inhibitors for Lung Cancer Annual Sales CAGR by Country/Region (2020, 2025 & 2031) & ($ millions)
Table 3. Major Players of Geftinib
Table 4. Major Players of Afatinib
Table 5. Major Players of Osimertinib
Table 6. Major Players of Other
Table 7. Global EGFR Inhibitors for Lung Cancer Sales by Type (2020-2024) & (K Units)
Table 8. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Type (2020-2024)
Table 9. Global EGFR Inhibitors for Lung Cancer Revenue by Type (2020-2024) & ($ million)
Table 10. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Type (2020-2024)
Table 11. Global EGFR Inhibitors for Lung Cancer Sale Price by Type (2020-2024) & (US$/Unit)
Table 12. Global EGFR Inhibitors for Lung Cancer Sales by Application (2020-2024) & (K Units)
Table 13. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Application (2020-2024)
Table 14. Global EGFR Inhibitors for Lung Cancer Revenue by Application (2020-2024)
Table 15. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Application (2020-2024)
Table 16. Global EGFR Inhibitors for Lung Cancer Sale Price by Application (2020-2024) & (US$/Unit)
Table 17. Global EGFR Inhibitors for Lung Cancer Sales by Company (2022-2024) & (K Units)
Table 18. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Company (2022-2024)
Table 19. Global EGFR Inhibitors for Lung Cancer Revenue by Company (2022-2024) ($ Millions)
Table 20. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Company (2022-2024)
Table 21. Global EGFR Inhibitors for Lung Cancer Sale Price by Company (2022-2024) & (US$/Unit)
Table 22. Key Manufacturers EGFR Inhibitors for Lung Cancer Producing Area Distribution and Sales Area
Table 23. Players EGFR Inhibitors for Lung Cancer Products Offered
Table 24. EGFR Inhibitors for Lung Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global EGFR Inhibitors for Lung Cancer Sales by Geographic Region (2020-2024) & (K Units)
Table 28. Global EGFR Inhibitors for Lung Cancer Sales Market Share Geographic Region (2020-2024)
Table 29. Global EGFR Inhibitors for Lung Cancer Revenue by Geographic Region (2020-2024) & ($ millions)
Table 30. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Geographic Region (2020-2024)
Table 31. Global EGFR Inhibitors for Lung Cancer Sales by Country/Region (2020-2024) & (K Units)
Table 32. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Country/Region (2020-2024)
Table 33. Global EGFR Inhibitors for Lung Cancer Revenue by Country/Region (2020-2024) & ($ millions)
Table 34. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Country/Region (2020-2024)
Table 35. Americas EGFR Inhibitors for Lung Cancer Sales by Country (2020-2024) & (K Units)
Table 36. Americas EGFR Inhibitors for Lung Cancer Sales Market Share by Country (2020-2024)
Table 37. Americas EGFR Inhibitors for Lung Cancer Revenue by Country (2020-2024) & ($ Millions)
Table 38. Americas EGFR Inhibitors for Lung Cancer Revenue Market Share by Country (2020-2024)
Table 39. Americas EGFR Inhibitors for Lung Cancer Sales by Type (2020-2024) & (K Units)
Table 40. Americas EGFR Inhibitors for Lung Cancer Sales Market Share by Type (2020-2024)
Table 41. Americas EGFR Inhibitors for Lung Cancer Sales by Application (2020-2024) & (K Units)
Table 42. Americas EGFR Inhibitors for Lung Cancer Sales Market Share by Application (2020-2024)
Table 43. APAC EGFR Inhibitors for Lung Cancer Sales by Region (2020-2024) & (K Units)
Table 44. APAC EGFR Inhibitors for Lung Cancer Sales Market Share by Region (2020-2024)
Table 45. APAC EGFR Inhibitors for Lung Cancer Revenue by Region (2020-2024) & ($ Millions)
Table 46. APAC EGFR Inhibitors for Lung Cancer Revenue Market Share by Region (2020-2024)
Table 47. APAC EGFR Inhibitors for Lung Cancer Sales by Type (2020-2024) & (K Units)
Table 48. APAC EGFR Inhibitors for Lung Cancer Sales Market Share by Type (2020-2024)
Table 49. APAC EGFR Inhibitors for Lung Cancer Sales by Application (2020-2024) & (K Units)
Table 50. APAC EGFR Inhibitors for Lung Cancer Sales Market Share by Application (2020-2024)
Table 51. Europe EGFR Inhibitors for Lung Cancer Sales by Country (2020-2024) & (K Units)
Table 52. Europe EGFR Inhibitors for Lung Cancer Sales Market Share by Country (2020-2024)
Table 53. Europe EGFR Inhibitors for Lung Cancer Revenue by Country (2020-2024) & ($ Millions)
Table 54. Europe EGFR Inhibitors for Lung Cancer Revenue Market Share by Country (2020-2024)
Table 55. Europe EGFR Inhibitors for Lung Cancer Sales by Type (2020-2024) & (K Units)
Table 56. Europe EGFR Inhibitors for Lung Cancer Sales Market Share by Type (2020-2024)
Table 57. Europe EGFR Inhibitors for Lung Cancer Sales by Application (2020-2024) & (K Units)
Table 58. Europe EGFR Inhibitors for Lung Cancer Sales Market Share by Application (2020-2024)
Table 59. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales by Country (2020-2024) & (K Units)
Table 60. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales Market Share by Country (2020-2024)
Table 61. Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue by Country (2020-2024) & ($ Millions)
Table 62. Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue Market Share by Country (2020-2024)
Table 63. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales by Type (2020-2024) & (K Units)
Table 64. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales Market Share by Type (2020-2024)
Table 65. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales by Application (2020-2024) & (K Units)
Table 66. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales Market Share by Application (2020-2024)
Table 67. Key Market Drivers & Growth Opportunities of EGFR Inhibitors for Lung Cancer
Table 68. Key Market Challenges & Risks of EGFR Inhibitors for Lung Cancer
Table 69. Key Industry Trends of EGFR Inhibitors for Lung Cancer
Table 70. EGFR Inhibitors for Lung Cancer Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. EGFR Inhibitors for Lung Cancer Distributors List
Table 73. EGFR Inhibitors for Lung Cancer Customer List
Table 74. Global EGFR Inhibitors for Lung Cancer Sales Forecast by Region (2025-2031) & (K Units)
Table 75. Global EGFR Inhibitors for Lung Cancer Sales Market Forecast by Region
Table 76. Global EGFR Inhibitors for Lung Cancer Revenue Forecast by Region (2025-2031) & ($ millions)
Table 77. Global EGFR Inhibitors for Lung Cancer Revenue Market Share Forecast by Region (2025-2031)
Table 78. Americas EGFR Inhibitors for Lung Cancer Sales Forecast by Country (2025-2031) & (K Units)
Table 79. Americas EGFR Inhibitors for Lung Cancer Revenue Forecast by Country (2025-2031) & ($ millions)
Table 80. APAC EGFR Inhibitors for Lung Cancer Sales Forecast by Region (2025-2031) & (K Units)
Table 81. APAC EGFR Inhibitors for Lung Cancer Revenue Forecast by Region (2025-2031) & ($ millions)
Table 82. Europe EGFR Inhibitors for Lung Cancer Sales Forecast by Country (2025-2031) & (K Units)
Table 83. Europe EGFR Inhibitors for Lung Cancer Revenue Forecast by Country (2025-2031) & ($ millions)
Table 84. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales Forecast by Country (2025-2031) & (K Units)
Table 85. Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue Forecast by Country (2025-2031) & ($ millions)
Table 86. Global EGFR Inhibitors for Lung Cancer Sales Forecast by Type (2025-2031) & (K Units)
Table 87. Global EGFR Inhibitors for Lung Cancer Sales Market Share Forecast by Type (2025-2031)
Table 88. Global EGFR Inhibitors for Lung Cancer Revenue Forecast by Type (2025-2031) & ($ Millions)
Table 89. Global EGFR Inhibitors for Lung Cancer Revenue Market Share Forecast by Type (2025-2031)
Table 90. Global EGFR Inhibitors for Lung Cancer Sales Forecast by Application (2025-2031) & (K Units)
Table 91. Global EGFR Inhibitors for Lung Cancer Sales Market Share Forecast by Application (2025-2031)
Table 92. Global EGFR Inhibitors for Lung Cancer Revenue Forecast by Application (2025-2031) & ($ Millions)
Table 93. Global EGFR Inhibitors for Lung Cancer Revenue Market Share Forecast by Application (2025-2031)
Table 94. Pfizer Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer EGFR Inhibitors for Lung Cancer Product Offered
Table 96. Pfizer EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. AstraZeneca Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca EGFR Inhibitors for Lung Cancer Product Offered
Table 101. AstraZeneca EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Genentech (Roche Group) Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 105. Genentech (Roche Group) EGFR Inhibitors for Lung Cancer Product Offered
Table 106. Genentech (Roche Group) EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 107. Genentech (Roche Group) Main Business
Table 108. Genentech (Roche Group) Latest Developments
Table 109. Beta Pharma Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 110. Beta Pharma EGFR Inhibitors for Lung Cancer Product Offered
Table 111. Beta Pharma EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 112. Beta Pharma Main Business
Table 113. Beta Pharma Latest Developments
Table 114. Mylan Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 115. Mylan EGFR Inhibitors for Lung Cancer Product Offered
Table 116. Mylan EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 117. Mylan Main Business
Table 118. Mylan Latest Developments
Table 119. Boehringer Ingelheim Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 120. Boehringer Ingelheim EGFR Inhibitors for Lung Cancer Product Offered
Table 121. Boehringer Ingelheim EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 122. Boehringer Ingelheim Main Business
Table 123. Boehringer Ingelheim Latest Developments
Table 124. Teva Pharmaceuticals Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offered
Table 126. Teva Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 127. Teva Pharmaceuticals Main Business
Table 128. Teva Pharmaceuticals Latest Developments
Table 129. Qilu Pharmaceutical Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 130. Qilu Pharmaceutical EGFR Inhibitors for Lung Cancer Product Offered
Table 131. Qilu Pharmaceutical EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 132. Qilu Pharmaceutical Main Business
Table 133. Qilu Pharmaceutical Latest Developments
Table 134. Betta Pharmaceuticals Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 135. Betta Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offered
Table 136. Betta Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 137. Betta Pharmaceuticals Main Business
Table 138. Betta Pharmaceuticals Latest Developments
Table 139. Haosen Pharmaceutical Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 140. Haosen Pharmaceutical EGFR Inhibitors for Lung Cancer Product Offered
Table 141. Haosen Pharmaceutical EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 142. Haosen Pharmaceutical Main Business
Table 143. Haosen Pharmaceutical Latest Developments
Table 144. ARIAD Pharmaceuticals Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 145. ARIAD Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offered
Table 146. ARIAD Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 147. ARIAD Pharmaceuticals Main Business
Table 148. ARIAD Pharmaceuticals Latest Developments
Table 149. HUTCHMED Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 150. HUTCHMED EGFR Inhibitors for Lung Cancer Product Offered
Table 151. HUTCHMED EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 152. HUTCHMED Main Business
Table 153. HUTCHMED Latest Developments
Table 154. Shanghai Ellis Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 155. Shanghai Ellis EGFR Inhibitors for Lung Cancer Product Offered
Table 156. Shanghai Ellis EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 157. Shanghai Ellis Main Business
Table 158. Shanghai Ellis Latest Developments
Table 159. Genvio Pharma Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 160. Genvio Pharma EGFR Inhibitors for Lung Cancer Product Offered
Table 161. Genvio Pharma EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 162. Genvio Pharma Main Business
Table 163. Genvio Pharma Latest Developments
Table 164. Everest Pharmaceuticals Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 165. Everest Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offered
Table 166. Everest Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 167. Everest Pharmaceuticals Main Business
Table 168. Everest Pharmaceuticals Latest Developments
Table 169. Incepta Pharmaceuticals Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 170. Incepta Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offered
Table 171. Incepta Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 172. Incepta Pharmaceuticals Main Business
Table 173. Incepta Pharmaceuticals Latest Developments
Table 174. Jiangsu Hengrui Medicine Basic Information, EGFR Inhibitors for Lung Cancer Manufacturing Base, Sales Area and Its Competitors
Table 175. Jiangsu Hengrui Medicine EGFR Inhibitors for Lung Cancer Product Offered
Table 176. Jiangsu Hengrui Medicine EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 177. Jiangsu Hengrui Medicine Main Business
Table 178. Jiangsu Hengrui Medicine Latest Developments
List of Figures
Figure 1. Picture of EGFR Inhibitors for Lung Cancer
Figure 2. EGFR Inhibitors for Lung Cancer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EGFR Inhibitors for Lung Cancer Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global EGFR Inhibitors for Lung Cancer Revenue Growth Rate 2020-2031 ($ Millions)
Figure 8. EGFR Inhibitors for Lung Cancer Sales by Region (2024 & 2031) & ($ millions)
Figure 9. Product Picture of Geftinib
Figure 10. Product Picture of Afatinib
Figure 11. Product Picture of Osimertinib
Figure 12. Product Picture of Other
Figure 13. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Type in 2024
Figure 14. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Type (2020-2024)
Figure 15. EGFR Inhibitors for Lung Cancer Consumed in Medical Care
Figure 16. Global EGFR Inhibitors for Lung Cancer Market: Medical Care (2020-2024) & (K Units)
Figure 17. EGFR Inhibitors for Lung Cancer Consumed in Experiment
Figure 18. Global EGFR Inhibitors for Lung Cancer Market: Experiment (2020-2024) & (K Units)
Figure 19. EGFR Inhibitors for Lung Cancer Consumed in Others
Figure 20. Global EGFR Inhibitors for Lung Cancer Market: Others (2020-2024) & (K Units)
Figure 21. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Application (2020-2024)
Figure 22. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Application in 2024
Figure 23. EGFR Inhibitors for Lung Cancer Revenue Market by Company in 2024 ($ Million)
Figure 24. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Company in 2024
Figure 25. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Geographic Region (2020-2024)
Figure 26. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Geographic Region in 2024
Figure 27. Global EGFR Inhibitors for Lung Cancer Sales Market Share by Region (2020-2024)
Figure 28. Global EGFR Inhibitors for Lung Cancer Revenue Market Share by Country/Region in 2024
Figure 29. Americas EGFR Inhibitors for Lung Cancer Sales 2020-2024 (K Units)
Figure 30. Americas EGFR Inhibitors for Lung Cancer Revenue 2020-2024 ($ Millions)
Figure 31. APAC EGFR Inhibitors for Lung Cancer Sales 2020-2024 (K Units)
Figure 32. APAC EGFR Inhibitors for Lung Cancer Revenue 2020-2024 ($ Millions)
Figure 33. Europe EGFR Inhibitors for Lung Cancer Sales 2020-2024 (K Units)
Figure 34. Europe EGFR Inhibitors for Lung Cancer Revenue 2020-2024 ($ Millions)
Figure 35. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales 2020-2024 (K Units)
Figure 36. Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue 2020-2024 ($ Millions)
Figure 37. Americas EGFR Inhibitors for Lung Cancer Sales Market Share by Country in 2024
Figure 38. Americas EGFR Inhibitors for Lung Cancer Revenue Market Share by Country in 2024
Figure 39. United States EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 40. Canada EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 41. Mexico EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 42. Brazil EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 43. APAC EGFR Inhibitors for Lung Cancer Sales Market Share by Region in 2024
Figure 44. APAC EGFR Inhibitors for Lung Cancer Revenue Market Share by Regions in 2024
Figure 45. China EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 46. Japan EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 47. South Korea EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 48. Southeast Asia EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 49. India EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 50. Australia EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 51. Europe EGFR Inhibitors for Lung Cancer Sales Market Share by Country in 2024
Figure 52. Europe EGFR Inhibitors for Lung Cancer Revenue Market Share by Country in 2024
Figure 53. Germany EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 54. France EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 55. UK EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 56. Italy EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 57. Russia EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 58. Middle East & Africa EGFR Inhibitors for Lung Cancer Sales Market Share by Country in 2024
Figure 59. Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue Market Share by Country in 2024
Figure 60. Egypt EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 61. South Africa EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 62. Israel EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 63. Turkey EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 64. GCC Country EGFR Inhibitors for Lung Cancer Revenue Growth 2020-2024 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of EGFR Inhibitors for Lung Cancer in 2024
Figure 66. Manufacturing Process Analysis of EGFR Inhibitors for Lung Cancer
Figure 67. Industry Chain Structure of EGFR Inhibitors for Lung Cancer
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles

※参考情報 肺がんは、世界中で最も一般的なさらには致死率の高いがんの一つであり、その治療法には多くの研究が行われています。その中でも、EGFR阻害剤は特に重要な役割を果たしている治療法の一つです。EGFRとは上皮成長因子受容体（Epidermal Growth Factor Receptor）の略で、細胞の成長や分裂を調節するタンパク質です。肺がん患者の中には、このEGFRが異常に活性化されている場合が多く、それががんの進行を助長します。EGFR阻害剤は、この受容体の働きを抑えることにより、がん細胞の成長を制御し、治療効果をもたらします。 EGFR阻害剤の特徴の一つは、特定の遺伝子変異に基づいて効果を示すことです。特に、肺腺癌に多く見られるEGFR遺伝子の変異、例えばエクソン19の欠失やエクソン21のL858R変異が関連しています。これらの変異が認められる患者さんにおいて、EGFR阻害剤は化学療法に比べて高い奏効率を示すことが多いです。そのため、EGFR遺伝子変異の有無を調べるためのバイオマーカー試験が、治療を始める前に行われることが一般的です。 EGFR阻害剤には主に2つのタイプがあります。一つは競合的阻害薬（第一世代EGFR阻害剤）で、代表的なものにはゲフィチニブ（Iressa）やエルロチニブ（Tarceva）が含まれます。これらは、EGFRの結合部位に結合し、受容体が活性化されるのを防ぎます。第二世代EGFR阻害剤には、ダナモチニブやアファチニブなどが知られています。これらはより強力にEGFRを阻害し、さらにT790M変異に対しても効果を持つものが開発されています。 続いて、第三世代EGFR阻害剤も登場しています。代表的なものにはオシメルチニブ（Tagrisso）があり、これはT790M変異を持つEGFR変異に対して特に効果的です。オシメルチニブは、他の世代のEGFR阻害剤に耐性を持つ患者に対しても治療効果を示すため、非常に有用な選択肢となります。これらのEGFR阻害剤は、単独で使用されることもあれば、他の治療法と組み合わせて使用されることもあります。 EGFR阻害剤の用途は主に、進行した非小細胞肺がん（NSCLC）の治療に限られています。特にEGFR変異陽性の非小細胞肺がん患者において高い治療効果が期待されています。また、EGFR阻害剤は初回治療だけでなく、再発した場合の治療としても用いられます。近年の研究では、早期段階での使用やネオアジュバント（術前）治療としての適応も拡がっています。 さらに、EGFR阻害剤の開発においては、個別化医療が重要なテーマとされています。患者ごとにEGFRの遺伝子型が異なるため、治療法の最適化が求められています。最近では、次世代シーケンシング技術を用いて、EGFRの他にも多様な遺伝子変異の同定が行われています。これにより、患者一人ひとりに応じたより効果的な治療戦略を立てることが可能となります。 EGFR阻害剤には、効果がある一方で副作用も存在します。代表的な副作用には皮膚の発疹、下痢、口内炎、疲労感などがあり、これらは患者のQOL（生活の質）に影響を及ぼすことがあります。特に皮膚の問題はEGFR阻害剤の使用中によく見られる副作用であり、適切なスキンケアが必要です。また、これらの副作用を管理するためには、医療チームとの密なコミュニケーションが不可欠です。 現在、EGFR阻害剤の研究は急速に進んでおり、新たな分子標的治療薬や、他の治療法との併用療法が開発されています。免疫チェックポイント阻害剤や抗血管新生療法などとの併用が検討されており、これにより効果が期待される新たな治療戦略が生まれています。また、治療の効果を評価するためのバイオマーカーの研究や新たな画像診断技術の開発も進められています。これにより、より効果的で安全な治療法の確立が期待されます。 EGFR阻害剤は、肺がん治療における大きな進歩の一つであり、多くの患者に希望をもたらしています。今後の研究によってさらなる効果的な治療法が見つかることを期待しつつ、患者さんへの支援が続けられることが重要です。EGFR阻害剤の治療を受ける全ての患者さんが、安全で効果的な治療を受けられるよう、医療現場での取り組みが求められています。治療の進展とともに、患者さん自身も治療に対する理解を深め、医療チームと連携しながら最適な道を選ぶことが必要です。整体的なサポートを通じて、肺がん治療の未来に向けた道が切り拓かれることに期待しています。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

It is a machine that can acquire the anatomical structure of the grayscale and color Doppler images of blood flow in real time.
The global market for Veterinary Ultrasound Diagnostic Equipment is estimated to increase from US$ million in 2024 to reach US$ million by 2031, exhibiting a CAGR of % during 2025-2031. Keeping in mind the uncertainties of Trade War and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of trade war on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Veterinary Ultrasound Diagnostic Equipment market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The United States Veterinary Ultrasound Diagnostic Equipment market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The Europe Veterinary Ultrasound Diagnostic Equipment market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The China Veterinary Ultrasound Diagnostic Equipment market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
Global key Veterinary Ultrasound Diagnostic Equipment players cover Esaote, BMV Technology, SIUI, Caresono and Hunan Fude Technology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2024.

[Report Coverage]
This latest report provides a deep insight into the global Veterinary Ultrasound Diagnostic Equipment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Veterinary Ultrasound Diagnostic Equipment market, with both quantitative and qualitative data, to help readers understand how the Veterinary Ultrasound Diagnostic Equipment market scenario changed across the globe during trade war and Russia-Ukraine War.
The base year considered for analyses is 2024, while the market estimates and forecasts are given from 2025 to 2031. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

[Market Segmentation]
The study segments the Veterinary Ultrasound Diagnostic Equipment market and forecasts the market size by Type (Desktop and Portable,), by Application (Animal Shelter, Pet Hospital, Pet Shop and Family), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Desktop
Portable
Segmentation by application
Animal Shelter
Pet Hospital
Pet Shop
Family
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Esaote
BMV Technology
SIUI
Caresono
Hunan Fude Technology
IMV Imaging
DISPOMEDICAL
Eickemeyer Veterinary Equipment
Guangzhou Longest Science & Technology
Promed Technology
DRAMINSKI
E.I. Medical Imaging
Clarius Mobile Health
Dawei Medical
Sonostar Technologies
Tecnovet
Wisonic
Diagnostic Imaging Systems
Ricso Technology
Shenzhen Afkmed
SonicVet
Wuhan J.H.Bio-Tech
Shenzhen Mindray Animal Medical Technology
Shenzhen Well.D Medical Electronics
Xianfeng Ultrasound Medical
Xuzhou Kaixin Electronic Instrument

[Chapter Introduction]
Chapter 1: Scope of Veterinary Ultrasound Diagnostic Equipment, Research Methodology, etc.
Chapter 2: Executive Summary, global Veterinary Ultrasound Diagnostic Equipment market size (sales and revenue) and CAGR, Veterinary Ultrasound Diagnostic Equipment market size by region, by type, by application, historical data from 2020 to 2025, and forecast to 2031.
Chapter 3: Veterinary Ultrasound Diagnostic Equipment sales, revenue, average price, global market share, and industry ranking by company, 2020-2024
Chapter 4: Global Veterinary Ultrasound Diagnostic Equipment sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Veterinary Ultrasound Diagnostic Equipment market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Esaote, BMV Technology, SIUI, Caresono, Hunan Fude Technology, IMV Imaging, DISPOMEDICAL, Eickemeyer Veterinary Equipment and Guangzhou Longest Science & Technology, etc.
Chapter 14: Research Findings and Conclusion

List of Tables
Table 1. Veterinary Ultrasound Diagnostic Equipment Annual Sales CAGR by Geographic Region (2020, 2025 & 2031) & ($ millions)
Table 2. Veterinary Ultrasound Diagnostic Equipment Annual Sales CAGR by Country/Region (2020, 2025 & 2031) & ($ millions)
Table 3. Major Players of Desktop
Table 4. Major Players of Portable
Table 5. Global Veterinary Ultrasound Diagnostic Equipment Sales by Type (2020-2024) & (K Units)
Table 6. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Type (2020-2024)
Table 7. Global Veterinary Ultrasound Diagnostic Equipment Revenue by Type (2020-2024) & ($ million)
Table 8. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Type (2020-2024)
Table 9. Global Veterinary Ultrasound Diagnostic Equipment Sale Price by Type (2020-2024) & (US$/Unit)
Table 10. Global Veterinary Ultrasound Diagnostic Equipment Sales by Application (2020-2024) & (K Units)
Table 11. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Application (2020-2024)
Table 12. Global Veterinary Ultrasound Diagnostic Equipment Revenue by Application (2020-2024)
Table 13. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Application (2020-2024)
Table 14. Global Veterinary Ultrasound Diagnostic Equipment Sale Price by Application (2020-2024) & (US$/Unit)
Table 15. Global Veterinary Ultrasound Diagnostic Equipment Sales by Company (2022-2024) & (K Units)
Table 16. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Company (2022-2024)
Table 17. Global Veterinary Ultrasound Diagnostic Equipment Revenue by Company (2022-2024) ($ Millions)
Table 18. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Company (2022-2024)
Table 19. Global Veterinary Ultrasound Diagnostic Equipment Sale Price by Company (2022-2024) & (US$/Unit)
Table 20. Key Manufacturers Veterinary Ultrasound Diagnostic Equipment Producing Area Distribution and Sales Area
Table 21. Players Veterinary Ultrasound Diagnostic Equipment Products Offered
Table 22. Veterinary Ultrasound Diagnostic Equipment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Veterinary Ultrasound Diagnostic Equipment Sales by Geographic Region (2020-2024) & (K Units)
Table 26. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share Geographic Region (2020-2024)
Table 27. Global Veterinary Ultrasound Diagnostic Equipment Revenue by Geographic Region (2020-2024) & ($ millions)
Table 28. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Geographic Region (2020-2024)
Table 29. Global Veterinary Ultrasound Diagnostic Equipment Sales by Country/Region (2020-2024) & (K Units)
Table 30. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country/Region (2020-2024)
Table 31. Global Veterinary Ultrasound Diagnostic Equipment Revenue by Country/Region (2020-2024) & ($ millions)
Table 32. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country/Region (2020-2024)
Table 33. Americas Veterinary Ultrasound Diagnostic Equipment Sales by Country (2020-2024) & (K Units)
Table 34. Americas Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country (2020-2024)
Table 35. Americas Veterinary Ultrasound Diagnostic Equipment Revenue by Country (2020-2024) & ($ Millions)
Table 36. Americas Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country (2020-2024)
Table 37. Americas Veterinary Ultrasound Diagnostic Equipment Sales by Type (2020-2024) & (K Units)
Table 38. Americas Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Type (2020-2024)
Table 39. Americas Veterinary Ultrasound Diagnostic Equipment Sales by Application (2020-2024) & (K Units)
Table 40. Americas Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Application (2020-2024)
Table 41. APAC Veterinary Ultrasound Diagnostic Equipment Sales by Region (2020-2024) & (K Units)
Table 42. APAC Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Region (2020-2024)
Table 43. APAC Veterinary Ultrasound Diagnostic Equipment Revenue by Region (2020-2024) & ($ Millions)
Table 44. APAC Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Region (2020-2024)
Table 45. APAC Veterinary Ultrasound Diagnostic Equipment Sales by Type (2020-2024) & (K Units)
Table 46. APAC Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Type (2020-2024)
Table 47. APAC Veterinary Ultrasound Diagnostic Equipment Sales by Application (2020-2024) & (K Units)
Table 48. APAC Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Application (2020-2024)
Table 49. Europe Veterinary Ultrasound Diagnostic Equipment Sales by Country (2020-2024) & (K Units)
Table 50. Europe Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country (2020-2024)
Table 51. Europe Veterinary Ultrasound Diagnostic Equipment Revenue by Country (2020-2024) & ($ Millions)
Table 52. Europe Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country (2020-2024)
Table 53. Europe Veterinary Ultrasound Diagnostic Equipment Sales by Type (2020-2024) & (K Units)
Table 54. Europe Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Type (2020-2024)
Table 55. Europe Veterinary Ultrasound Diagnostic Equipment Sales by Application (2020-2024) & (K Units)
Table 56. Europe Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Application (2020-2024)
Table 57. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales by Country (2020-2024) & (K Units)
Table 58. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country (2020-2024)
Table 59. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Revenue by Country (2020-2024) & ($ Millions)
Table 60. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country (2020-2024)
Table 61. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales by Type (2020-2024) & (K Units)
Table 62. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Type (2020-2024)
Table 63. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales by Application (2020-2024) & (K Units)
Table 64. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Application (2020-2024)
Table 65. Key Market Drivers & Growth Opportunities of Veterinary Ultrasound Diagnostic Equipment
Table 66. Key Market Challenges & Risks of Veterinary Ultrasound Diagnostic Equipment
Table 67. Key Industry Trends of Veterinary Ultrasound Diagnostic Equipment
Table 68. Veterinary Ultrasound Diagnostic Equipment Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Veterinary Ultrasound Diagnostic Equipment Distributors List
Table 71. Veterinary Ultrasound Diagnostic Equipment Customer List
Table 72. Global Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Region (2025-2031) & (K Units)
Table 73. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Forecast by Region
Table 74. Global Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Region (2025-2031) & ($ millions)
Table 75. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share Forecast by Region (2025-2031)
Table 76. Americas Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Country (2025-2031) & (K Units)
Table 77. Americas Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Country (2025-2031) & ($ millions)
Table 78. APAC Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Region (2025-2031) & (K Units)
Table 79. APAC Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Region (2025-2031) & ($ millions)
Table 80. Europe Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Country (2025-2031) & (K Units)
Table 81. Europe Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Country (2025-2031) & ($ millions)
Table 82. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Country (2025-2031) & (K Units)
Table 83. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Country (2025-2031) & ($ millions)
Table 84. Global Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Type (2025-2031) & (K Units)
Table 85. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share Forecast by Type (2025-2031)
Table 86. Global Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Type (2025-2031) & ($ Millions)
Table 87. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share Forecast by Type (2025-2031)
Table 88. Global Veterinary Ultrasound Diagnostic Equipment Sales Forecast by Application (2025-2031) & (K Units)
Table 89. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share Forecast by Application (2025-2031)
Table 90. Global Veterinary Ultrasound Diagnostic Equipment Revenue Forecast by Application (2025-2031) & ($ Millions)
Table 91. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share Forecast by Application (2025-2031)
Table 92. Esaote Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 93. Esaote Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 94. Esaote Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 95. Esaote Main Business
Table 96. Esaote Latest Developments
Table 97. BMV Technology Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 98. BMV Technology Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 99. BMV Technology Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 100. BMV Technology Main Business
Table 101. BMV Technology Latest Developments
Table 102. SIUI Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 103. SIUI Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 104. SIUI Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 105. SIUI Main Business
Table 106. SIUI Latest Developments
Table 107. Caresono Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 108. Caresono Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 109. Caresono Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 110. Caresono Main Business
Table 111. Caresono Latest Developments
Table 112. Hunan Fude Technology Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 113. Hunan Fude Technology Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 114. Hunan Fude Technology Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 115. Hunan Fude Technology Main Business
Table 116. Hunan Fude Technology Latest Developments
Table 117. IMV Imaging Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 118. IMV Imaging Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 119. IMV Imaging Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 120. IMV Imaging Main Business
Table 121. IMV Imaging Latest Developments
Table 122. DISPOMEDICAL Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 123. DISPOMEDICAL Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 124. DISPOMEDICAL Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 125. DISPOMEDICAL Main Business
Table 126. DISPOMEDICAL Latest Developments
Table 127. Eickemeyer Veterinary Equipment Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 128. Eickemeyer Veterinary Equipment Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 129. Eickemeyer Veterinary Equipment Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 130. Eickemeyer Veterinary Equipment Main Business
Table 131. Eickemeyer Veterinary Equipment Latest Developments
Table 132. Guangzhou Longest Science & Technology Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 133. Guangzhou Longest Science & Technology Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 134. Guangzhou Longest Science & Technology Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 135. Guangzhou Longest Science & Technology Main Business
Table 136. Guangzhou Longest Science & Technology Latest Developments
Table 137. Promed Technology Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 138. Promed Technology Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 139. Promed Technology Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 140. Promed Technology Main Business
Table 141. Promed Technology Latest Developments
Table 142. DRAMINSKI Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 143. DRAMINSKI Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 144. DRAMINSKI Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 145. DRAMINSKI Main Business
Table 146. DRAMINSKI Latest Developments
Table 147. E.I. Medical Imaging Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 148. E.I. Medical Imaging Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 149. E.I. Medical Imaging Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 150. E.I. Medical Imaging Main Business
Table 151. E.I. Medical Imaging Latest Developments
Table 152. Clarius Mobile Health Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 153. Clarius Mobile Health Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 154. Clarius Mobile Health Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 155. Clarius Mobile Health Main Business
Table 156. Clarius Mobile Health Latest Developments
Table 157. Dawei Medical Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 158. Dawei Medical Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 159. Dawei Medical Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 160. Dawei Medical Main Business
Table 161. Dawei Medical Latest Developments
Table 162. Sonostar Technologies Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 163. Sonostar Technologies Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 164. Sonostar Technologies Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 165. Sonostar Technologies Main Business
Table 166. Sonostar Technologies Latest Developments
Table 167. Tecnovet Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 168. Tecnovet Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 169. Tecnovet Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 170. Tecnovet Main Business
Table 171. Tecnovet Latest Developments
Table 172. Wisonic Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 173. Wisonic Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 174. Wisonic Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 175. Wisonic Main Business
Table 176. Wisonic Latest Developments
Table 177. Diagnostic Imaging Systems Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 178. Diagnostic Imaging Systems Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 179. Diagnostic Imaging Systems Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 180. Diagnostic Imaging Systems Main Business
Table 181. Diagnostic Imaging Systems Latest Developments
Table 182. Ricso Technology Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 183. Ricso Technology Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 184. Ricso Technology Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 185. Ricso Technology Main Business
Table 186. Ricso Technology Latest Developments
Table 187. Shenzhen Afkmed Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 188. Shenzhen Afkmed Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 189. Shenzhen Afkmed Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 190. Shenzhen Afkmed Main Business
Table 191. Shenzhen Afkmed Latest Developments
Table 192. SonicVet Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 193. SonicVet Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 194. SonicVet Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 195. SonicVet Main Business
Table 196. SonicVet Latest Developments
Table 197. Wuhan J.H.Bio-Tech Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 198. Wuhan J.H.Bio-Tech Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 199. Wuhan J.H.Bio-Tech Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 200. Wuhan J.H.Bio-Tech Main Business
Table 201. Wuhan J.H.Bio-Tech Latest Developments
Table 202. Shenzhen Mindray Animal Medical Technology Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 203. Shenzhen Mindray Animal Medical Technology Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 204. Shenzhen Mindray Animal Medical Technology Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 205. Shenzhen Mindray Animal Medical Technology Main Business
Table 206. Shenzhen Mindray Animal Medical Technology Latest Developments
Table 207. Shenzhen Well.D Medical Electronics Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 208. Shenzhen Well.D Medical Electronics Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 209. Shenzhen Well.D Medical Electronics Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 210. Shenzhen Well.D Medical Electronics Main Business
Table 211. Shenzhen Well.D Medical Electronics Latest Developments
Table 212. Xianfeng Ultrasound Medical Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 213. Xianfeng Ultrasound Medical Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 214. Xianfeng Ultrasound Medical Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 215. Xianfeng Ultrasound Medical Main Business
Table 216. Xianfeng Ultrasound Medical Latest Developments
Table 217. Xuzhou Kaixin Electronic Instrument Basic Information, Veterinary Ultrasound Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 218. Xuzhou Kaixin Electronic Instrument Veterinary Ultrasound Diagnostic Equipment Product Offered
Table 219. Xuzhou Kaixin Electronic Instrument Veterinary Ultrasound Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 220. Xuzhou Kaixin Electronic Instrument Main Business
Table 221. Xuzhou Kaixin Electronic Instrument Latest Developments
List of Figures
Figure 1. Picture of Veterinary Ultrasound Diagnostic Equipment
Figure 2. Veterinary Ultrasound Diagnostic Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Ultrasound Diagnostic Equipment Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Veterinary Ultrasound Diagnostic Equipment Revenue Growth Rate 2020-2031 ($ Millions)
Figure 8. Veterinary Ultrasound Diagnostic Equipment Sales by Region (2024 & 2031) & ($ millions)
Figure 9. Product Picture of Desktop
Figure 10. Product Picture of Portable
Figure 11. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Type in 2024
Figure 12. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Type (2020-2024)
Figure 13. Veterinary Ultrasound Diagnostic Equipment Consumed in Animal Shelter
Figure 14. Global Veterinary Ultrasound Diagnostic Equipment Market: Animal Shelter (2020-2024) & (K Units)
Figure 15. Veterinary Ultrasound Diagnostic Equipment Consumed in Pet Hospital
Figure 16. Global Veterinary Ultrasound Diagnostic Equipment Market: Pet Hospital (2020-2024) & (K Units)
Figure 17. Veterinary Ultrasound Diagnostic Equipment Consumed in Pet Shop
Figure 18. Global Veterinary Ultrasound Diagnostic Equipment Market: Pet Shop (2020-2024) & (K Units)
Figure 19. Veterinary Ultrasound Diagnostic Equipment Consumed in Family
Figure 20. Global Veterinary Ultrasound Diagnostic Equipment Market: Family (2020-2024) & (K Units)
Figure 21. Veterinary Ultrasound Diagnostic Equipment Consumed in Others
Figure 22. Global Veterinary Ultrasound Diagnostic Equipment Market: Others (2020-2024) & (K Units)
Figure 23. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Application (2020-2024)
Figure 24. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Application in 2024
Figure 25. Veterinary Ultrasound Diagnostic Equipment Revenue Market by Company in 2024 ($ Million)
Figure 26. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Company in 2024
Figure 27. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Geographic Region (2020-2024)
Figure 28. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Geographic Region in 2024
Figure 29. Global Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Region (2020-2024)
Figure 30. Global Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country/Region in 2024
Figure 31. Americas Veterinary Ultrasound Diagnostic Equipment Sales 2020-2024 (K Units)
Figure 32. Americas Veterinary Ultrasound Diagnostic Equipment Revenue 2020-2024 ($ Millions)
Figure 33. APAC Veterinary Ultrasound Diagnostic Equipment Sales 2020-2024 (K Units)
Figure 34. APAC Veterinary Ultrasound Diagnostic Equipment Revenue 2020-2024 ($ Millions)
Figure 35. Europe Veterinary Ultrasound Diagnostic Equipment Sales 2020-2024 (K Units)
Figure 36. Europe Veterinary Ultrasound Diagnostic Equipment Revenue 2020-2024 ($ Millions)
Figure 37. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales 2020-2024 (K Units)
Figure 38. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Revenue 2020-2024 ($ Millions)
Figure 39. Americas Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country in 2024
Figure 40. Americas Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country in 2024
Figure 41. United States Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 42. Canada Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 43. Mexico Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 44. Brazil Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 45. APAC Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Region in 2024
Figure 46. APAC Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Regions in 2024
Figure 47. China Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 48. Japan Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 49. South Korea Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 50. Southeast Asia Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 51. India Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 52. Australia Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 53. Europe Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country in 2024
Figure 54. Europe Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country in 2024
Figure 55. Germany Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 56. France Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 57. UK Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 58. Italy Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 59. Russia Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 60. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Sales Market Share by Country in 2024
Figure 61. Middle East & Africa Veterinary Ultrasound Diagnostic Equipment Revenue Market Share by Country in 2024
Figure 62. Egypt Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 63. South Africa Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 64. Israel Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 65. Turkey Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 66. GCC Country Veterinary Ultrasound Diagnostic Equipment Revenue Growth 2020-2024 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Veterinary Ultrasound Diagnostic Equipment in 2024
Figure 68. Manufacturing Process Analysis of Veterinary Ultrasound Diagnostic Equipment
Figure 69. Industry Chain Structure of Veterinary Ultrasound Diagnostic Equipment
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

※参考情報 動物用超音波診断装置は、獣医学において重要な役割を果たす診断機器の一つです。この装置は、獣医師が動物の内部構造を非侵襲的に観察し、診断を行うために利用されます。超音波診断装置は、高周波の音波を用いて体内の画像を生成します。これにより、動物の様々な健康状態を評価する手助けとなり、病気の早期発見や治療計画の立案に寄与します。以下に、動物用超音波診断装置の定義、特徴、種類、用途、および関連技術について詳しく説明します。 まず、動物用超音波診断装置の定義について考えます。この装置は、音波を利用して体の内部の画像を作成し、これを元に診断を行う医療機器です。一般的に、超音波は人間の耳には聞こえない周波数帯域（20kHz以上）で発振され、体内に送信されます。超音波が体内の臓器や組織に当たると、その反射信号が戻ってきます。この信号を解析することで、臓器の形状や大きさ、構造の異常を検出できます。 次に、動物用超音波診断装置の特徴を述べます。まず、非侵襲的な検査方法であるため、動物に対する負担が少なく、ストレスを軽減できる点が挙げられます。また、リアルタイムでの画像確認が可能であり、動物の状態を即座に観察することができます。さらに、さまざまな動物種に対応できる柔軟性があり、小型犬から大型動物、さらには野生動物にまで使用されます。加えて、装置の操作は比較的簡易であり、獣医師が少ないトレーニングで扱えることも利点の一つです。 動物用超音波診断装置には、いくつかの種類があります。最も一般的なものは、腹部超音波診断装置です。これは、消化器系や循環器系の異常を評価するために使用されます。心臓超音波診断装置（エコー）は、心臓の構造や機能を詳しく検査するために特化した装置です。産科用超音波診断装置は、妊娠の確認や胎児の状態を評価するために利用されます。また、関節や筋肉の評価を行うための筋骨格系超音波診断装置も存在します。これにより、動物の整形外科的な問題を早期に発見することができます。 動物用超音波診断装置の用途は多岐にわたります。主な用途としては、病気の診断、健康状態のモニタリング、治療計画の策定、さらには手術のガイドとしての利用が挙げられます。例えば、腫瘍の検出や炎症の評価により、早期の治療へとつなげることができます。また、超音波ガイド下での針生検や水分吸引手技を行うことも一般的で、正確な位置にアプローチするための重要な道具となります。さらに、妊娠診断により繁殖管理を行うことができ、獣医師が飼い主に対して適切なアドバイスを提供するのに役立ちます。 関連技術としては、画像解析技術や人工知能（AI）の導入が進んでいます。これにより、画像の解析速度が向上し、診断精度の向上が期待されます。また、超音波診断装置と他の診断技術（X線やCTスキャンなど）を組み合わせることで、より詳細な情報を取得することが可能です。例えば、超音波診断で異常が見つかった部分をX線でさらに詳しく調査することで、異常の範囲や性質を特定できることがあります。 さらに、ポータブルタイプの超音波診断装置が開発されており、これにより、診療所だけでなく、現場や自宅での診断も可能となりました。特に、救急医療や野生動物の保護活動においては、このような portable ultrasound の利用が重要です。 このように、動物用超音波診断装置は、獣医診療において欠かせないツールとなっており、その用途や技術は進化し続けています。非侵襲的でありながら高い診断能力を持つこの装置は、今後の獣医療の発展に大きく貢献することでしょう。動物の健康管理や病気の早期発見、適切な治療の施行に寄与し、飼い主にとっても安心感を提供する役割を果たしています。獣医師が最新の超音波診断技術を理解し、適切に使用することが、動物の健康を守るために極めて重要であることは言うまでもありません。今後も、この分野はより一層の進化が期待され、多様な動物科のニーズに応えられるよう技術開発が進むことでしょう。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/